RT @Oncotarget: #PaperoftheDay: "Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma" DOI: ht…

#PaperoftheDay: "Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma" DOI: https://t.co/5wvs9k8juU #cancerresearch #oncology #OA #MedEd

Oncotarget recently #published this #trendingwithimpact editorial: “Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma." https://t.co/5wvs9k8juU #cancer #melanoma #research #editorial #openaccess #publishing #

Oncotarget recently #published this #trendingwithimpact editorial: “Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma." https://t.co/5wvs9k8juU #cancer #melanoma #research #editorial #openaccess #publishing #

#TrendingWithImpact: On May 26, 2023, researchers from @UniVerona and Italy's Institute for Cancer Research and Prevention published a new editorial: “Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma.” DOI:

Oncotarget recently #published this #trendingwithimpact editorial: “Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma." https://t.co/5wvs9k8juU #cancer #melanoma #research #editorial #openaccess #publishing #

NEW #PaperoftheDay: "Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma" https://t.co/5wvs9k8juU #cancerresearch #oncology #openaccess #peerreviewed #medEd #OA

Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma. https://t.co/DKjNZPGtAq https://t.co/3lVLeBXxi7